TQH3906-III-01: A Clinical Trial of TQH3906 Capsules in Adult Patients With Moderate to Severe Plaque Psoriasis (clinicaltrials.gov) - Sep 10, 2026 - P3 | N=400 | Recruiting | Sponsor: Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | Not yet recruiting ➔ Recruiting
Enrollment open • Dermatology • Immunology • Psoriasis
|